Skip to content

Released Feb 26, 2021, before the open

10-K filed Feb 26, 2021, 57 days after period end · 0001564590-21-009214

Q4 2020 · 10-K

derived · Computed from the longer spans the company filed.

Revenue$117.62Mderived−3.2% vs Q4 2019+6.0% vs Q3 2020
Net Income-$9.38MderivedN/M vs Q4 2019N/M vs Q3 2020
EPS, diluted—Not derived. Share counts vary by quarter.
Gross Profitderived$88,548,000−7.1%
Operating Incomederived$3,705,000−9.5%
Operating Cash Flowderived$22,291,000+86.6%
Free Cash Flowderived$18,431,000+175.8%
Margins · derived
Gross margin75.3%−3.2 pt vs Q4 2019
Operating margin3.2%−0.2 pt vs Q4 2019
Net margin-8.0%−17.6 pt vs Q4 2019

What the release said

The release

Same quarter

MetricQ4 2020derived from reported figuresQ4 2019Q4 2018Q4 2017
Revenue$117.62M$121.49M$121.08M$116.90M
Net Income-$9.38M$11.69M$8.87M$1.57M
EPS Diluted—$0.60$0.46$0.08

The same fiscal quarter, prior years. Thaler holds no estimates to compare against.

Orthofix Medical Inc. · CIK 884624 · Engraved from SEC EDGAR